Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ISY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00908 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBBP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BTBD7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDHD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POU2F1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPRO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCN15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC77 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIGYF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MDM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBED8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on